Pre- and Postoperative Cell-Free Fetal DNA Analyses for Detecting Aneuploidy in Early Pregnancy Loss: Single-Center Prospective Cohort Study
Open Access
Abstract
Background/Objective: Early pregnancy loss is often caused by chromosomal abnormalities, necessitating accurate diagnostic tools. While product of conception (POC) chromosomal testing is commonly used, it can be limited by culture failure or an inability to obtain fetal tissue due to spontaneous expulsion. Cell-free fetal DNA (cff DNA) analysis provides a non-invasive alternative; however, its effectiveness in early pregnancy loss, particularly in cases where fetal components are still minimal, has not been fully established. The objective of this study was to evaluate the accuracy of pre- and postoperative cff DNA analysis for detecting fetal aneuploidy by comparing the results to those of POC chromosomal testing. Methods: In this single-center prospective cohort study, 50 women undergoing manual vacuum aspiration for pregnancy loss before 12 weeks of gestation were enrolled (February 2022–December 2024). Cff DNA analysis was performed on maternal blood samples collected pre- and postoperatively. The primary outcome was concordance between the cff DNA and POC results. Sensitivity, specificity, and factors affecting concordance were also assessed. Results: Eight participants were excluded due to unsuccessful POC culture (n = 3), suspected maternal tissue contamination in the POC sample (n = 1), mosaicism (n = 3), or triploidy (n = 1), resulting in 42 evaluable cases. Preoperative cff DNA analysis showed 88.1% concordance with POC (sensitivity 86.4% and specificity 90.0%). Postoperative analysis showed 78.6% concordance (sensitivity 72.7% and specificity 85.0%). Conclusions: The Cff DNA analysis of preoperative and postoperative maternal blood samples showed generally good concordance with conventional POC chromosomal testing in detecting fetal aneuploidy in early pregnancy loss.Keywords
Funding Information
- JSPS KAKENHI (JP23K07256)
This publication has 30 references indexed in Scilit:
- Accuracy of cell‐free fetal DNA in detecting chromosomal anomalies in women experiencing miscarriage: systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2024
- Performance of prenatal cfDNA screening for sex chromosomesGenetics in Medicine, 2023
- Cell-free fetal DNA for genetic evaluation in Copenhagen Pregnancy Loss Study (COPL): a prospective cohort studyThe Lancet, 2023
- Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 studyThe American Journal of Human Genetics, 2022
- Total number of reads affects the accuracy of fetal fraction estimates in NIPTMolecular Genetics & Genomic Medicine, 2021
- Added value of chromosomal microarray analysis over karyotyping in early pregnancy loss: systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2018
- Determination of fetal DNA fraction from the plasma of pregnant women using sequence read countsPrenatal Diagnosis, 2015
- Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysisUltrasound in Obstetrics & Gynecology, 2015
- Evaluation and treatment of recurrent pregnancy loss: a committee opinionFertility and Sterility, 2012
- Persistent elevation of cell-free fetal DNA levels in maternal plasma after selective laser coagulation of chorionic plate anastomoses in severe midgestational twin-twin transfusion syndromeAmerican Journal of Obstetrics and Gynecology, 2005